Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its boronic acid functionality enables participation in Suzuki-Miyaura cross-coupling reactions, making it valuable in medicinal chemistry for constructing carbon-carbon bonds. The fluorophenyl and cyanomethyl groups enhance binding selectivity and metabolic stability in drug candidates. Commonly employed in research settings for the preparation of novel therapeutic agents targeting cancer, inflammation, and central nervous system disorders.